Guo, L., Lin, P., Xiong, H., Tu, S., & Chen, G. (2018). Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment. Biochimica et Biophysica Acta. https://doi.org/10.1016/j.bbcan.2018.01.001 (Original work published 2018)

Xiong, H., Yan, T., Zhang, W., Shi, F., Jiang, X., Wang, X., … Zhu, Y. (2018). miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2018.01.013 (Original work published 2018)

Gray, H., Bell-McGuinn, K., Fleming, G., Cristea, M., Xiong, H., Sullivan, D., … Martin, L. (2018). Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.12.029 (Original work published 2018)